Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer.

Mark D DaneseJennifer SchenfeldJaime ShawPrasad GawadeAkhila BalasubramanianMichael KelshRohini K HernandezGary Lyman

Published in: Advances in therapy (2022)

The use of G-CSF in patients diagnosed with breast and lung cancer is associated with an increased risk of MDS-AML. However, the MDS-AML absolute risk difference is very low.

Keyphrases

acute myeloid leukemia
prostate cancer
allogeneic hematopoietic stem cell transplantation
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
radical prostatectomy
patient reported outcomes
community dwelling